Home/Filings/4/0001415889-25-009959
4//SEC Filing

Haviland Kate 4

Accession 0001415889-25-009959

CIK 0001597264other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:30 PM ET

Size

10.8 KB

Accession

0001415889-25-009959

Insider Transaction Report

Form 4
Period: 2025-04-01
Haviland Kate
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Sale

    Common Stock

    2025-04-01$85.47/sh600$51,282167,827 total
  • Sale

    Common Stock

    2025-04-01$86.14/sh598$51,512167,229 total
  • Sale

    Common Stock

    2025-04-01$87.34/sh1,200$104,808166,029 total
  • Sale

    Common Stock

    2025-04-01$88.59/sh100$8,859165,929 total
Footnotes (4)
  • [F1]Effected pursuant to a trading plan adopted on August 30, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F2]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $84.93 to $85.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $85.93 to $86.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $86.97 to $87.95. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeother

Related Parties

1
  • filerCIK 0001663022

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:30 PM ET
Size
10.8 KB